PPI Versus Placebo in Severe Functional Heartburn

Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms

NCT00703534 ·Status: COMPLETED ·Phase: PHASE2

Determining Risk Factors for Successful PPI Weaning

NCT03226054 ·Status: TERMINATED ·Phase: NA

Fexofenadine Use in Gastroesophageal Reflux Symptoms

NCT03425097 ·Status: TERMINATED ·Phase: PHASE2

Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery

NCT01241149 ·Status: TERMINATED ·Phase: NA

Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment

NCT00204698 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease

NCT02533349 ·Status: UNKNOWN ·Phase: PHASE3

Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment

NCT00857597 ·Status: TERMINATED ·Phase: PHASE3

The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study

NCT02359604 ·Status: COMPLETED ·Phase: NA

Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication

NCT02934152 ·Status: UNKNOWN ·Phase: PHASE4

Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients

NCT01872897 ·Status: COMPLETED ·Phase: PHASE3

Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

NCT00171483 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of DA-5204 on Gastroesophageal Reflux Disease

NCT03998969 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of XP19986 in Subjects With Symptomatic GERD

NCT00557401 ·Status: COMPLETED ·Phase: PHASE2

Response to Supplement and Placebo in GERD

NCT01915173 ·Status: COMPLETED ·Phase: NA

Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

NCT00171418 ·Status: COMPLETED ·Phase: PHASE3

Platelet Rich Plasma in Hiatal Hernia Repair

NCT05023174 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Prucalopride Treatment for Refractory Gastro-esophageal Reflux Disease

NCT03676374 ·Status: UNKNOWN ·Phase: PHASE4

Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression

NCT00444236 ·Status: TERMINATED ·Phase: PHASE1

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US

NCT00795093 ·Status: COMPLETED

Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea

NCT01018160 ·Status: COMPLETED

Medical and Surgical Treatment of Esophageal Reflux

NCT00061724 ·Status: COMPLETED

The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors

NCT01404832 ·Status: TERMINATED ·Phase: PHASE4

Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.

NCT01601379 ·Status: COMPLETED

Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of Heartburn

NCT01037452 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD

NCT05879029 ·Status: RECRUITING ·Phase: PHASE4